BioCentury
ARTICLE | Clinical News

BG-777: Phase I

October 14, 2002 7:00 AM UTC

Virocell said 1 week of daily 0.05-50 ?g/kg doses of BG-777 were safe in an open-label, dose-escalation Canadian Phase I trial in 19 healthy volunteers. According to the company, BG-777 also was well ...